X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/18/2865286/0/en/Benitec-Biopharma-Reports-Positive-Interim-Clinical-Trial-Data-for-First-OPMD-Subject-Treated-with-BB-301-in-Phase-1b-2a-Study.html
https://www.globenewswire.com/news-release/2024/04/18/2865234/0/en/Benitec-Biopharma-Announces-Oversubscribed-Private-Placement-Financing-of-40-0-Million.html
https://www.globenewswire.com/news-release/2024/04/09/2859952/0/en/Benitec-Biopharma-to-Host-Virtual-R-D-Day-to-Discuss-BB-301-Clinical-Program-in-Oculopharyngeal-Muscular-Dystrophy-on-April-18-2024.html
https://www.globenewswire.com//news-release/2024/02/13/2828183/0/en/Benitec-Biopharma-Releases-Second-Quarter-2024-Financial-Results-and-Provides-Operational-Update.html
https://www.globenewswire.com//news-release/2023/11/30/2788463/0/en/Benitec-Biopharma-Announces-First-Subject-Dosed-in-Phase-1b-2a-Clinical-Trial-for-Gene-Therapy-Candidate-BB-301-for-the-Treatment-of-Oculopharyngeal-Muscular-Dystrophy.html
https://www.globenewswire.com//news-release/2023/11/17/2782543/0/en/Benitec-Biopharma-to-Participate-in-a-Fireside-Chat-at-the-35th-Annual-Piper-Sandler-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2023/11/13/2778994/0/en/Benitec-Biopharma-Releases-First-Quarter-2024-Financial-Results-and-Provides-Operational-Update.html
https://www.globenewswire.com//news-release/2023/09/21/2747204/0/en/Benitec-Biopharma-Releases-Full-Year-2023-Financial-Results-and-Provides-Operational-Update.html
https://www.globenewswire.com/news-release/2023/08/11/2723781/0/en/Benitec-Biopharma-Inc-Announces-Closing-of-30-Million-Underwritten-Public-Offering.html
https://www.globenewswire.com/news-release/2023/08/09/2721285/0/en/Benitec-Biopharma-Inc-Announces-Pricing-of-30-Million-Underwritten-Public-Offering.html
Market Place
Share 
